B7 score and T cell infiltration stratify immune status in prostate cancer

BACKGROUND: Although immune checkpoint inhibitors (ICIs), especially programmed cell death protein 1 (PD-1)/programmed death ligand 1 (PD-L1) axis blockers, exhibit prominent antitumor effects against numerous malignancies, their benefit for patients with prostate cancer (PCa) has been somewhat marg...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qianghua, Li, Kaiwen, Lai, Yiming, Yao, Kai, Wang, Qiong, Zhan, Xiangyu, Peng, Shirong, Cai, Wenli, Yao, Wei, Zang, Xingxing, Xu, Kewei, Huang, Jian, Huang, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381330/
https://www.ncbi.nlm.nih.gov/pubmed/34417325
http://dx.doi.org/10.1136/jitc-2021-002455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381330/
https://www.ncbi.nlm.nih.gov/pubmed/34417325
http://dx.doi.org/10.1136/jitc-2021-002455

Ejemplares similares